References
- Berman D, Crump K. 2008. A meta-analysis of asbestos related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 38(Suppl 1):49–73.
- Berman DW. 2011. Apples to apples: the origin and magnitude of differences in asbestos cancer risk estimates derived using varying protocols. Risk Anal. 31(8):1308–1326.
- Craighead J, Gibbs A. 2008. Asbestos and its disease. Oxford University Press; p. 403.
- Hodgson J, Darnton A. 2000. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 44(8):565–601.
- Darnton A, Health and Safety Executive [HSE]. 2010. Assessment of recently updated information relating to cohorts with chrysotile exposure. [accessed 2020 April 27]. https://webarchive.nationalarchives.gov.uk/20170110231916/http:/www.hse.gov.uk/aboutus/meetings/iacs/acts/watch/271010/watch-october-2010-additional-chrysotile-exposure.pdf.
- Moolgavkar S, Turim J, Alexander D, Lau E, Cushing C. 2010. Potency factors for risk assessment at Libby, Montana. Risk Anal: Off Publ Soc Risk Anal. 30(8):1240–1248.
- USCA. 2019. United States Court of Appeals for the Ninth Circuit. Decision No. 17-72260. [accessed 2020 Jul 1]. https://cdn.ca9.uscourts.gov/datastore/opinions/2019/11/14/17-72260.pdf.
- United States Environmental Protection Agency [US EPA]. Integrated Risk Information System (IRIS). 2020. [accessed 2020 April 27]. https://www.epa.gov/iris.
- United States Environmental Protection Agency [US EPA]. 1986. Airborne Asbestos Health Assessment Update. EPA/600/8-84/003F.
- US EPA. 2008. Framework for Investigating Asbestos-Contaminated Superfund Sites. OSWER Directive #9200.0-68.
- US EPA. 2009. Risk assessment guidance for superfund volume I: Human health evaluation manual (Part F, supplemental guidance for inhalation risk assessment).
- United States Environmental Protection Agency. [US EPA]. Toxicological Review of Libby Amphibole Asbestos. 2014. EPA/635/R-11/002F.